ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Effectiveness of an Adaptive Treatment Model for At-Risk Family Caregivers

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Effectiveness of an Adaptive Treatment Model for At-Risk Family Caregivers
Official Title  Adaptive Intervention for At-Risk Family Caregivers
Brief Summary

This study will develop and evaluate the effectiveness of an adaptive treatment model for reducing the stress of, and burden on, family members caring for a person with dementia.

Detailed Description

Caring for a person with dementia can be a highly stressful experience associated with a variety of negative outcomes. Family caregivers are more likely than noncaregivers to experience symptoms of depression and anxiety, feelings of anger, and health problems. Although there are multiple treatment models to address the adverse mental and physical health outcomes associated with caregiving, most do not account for the specific risk and protective factor differences among caregivers of people with dementia. Such models provide the same treatment to all participants and have demonstrated only limited success in this high-risk caregiver population. An adaptive treatment model based on the Stress Process Model of caregiving, which emphasizes that there are multiple factors that affect stress, social support, and mental health, may better meet the needs of family caregivers. This study will first develop an adaptive treatment model, based on the Stress Process Model, for family caregivers of a person suffering from dementia. The study will then evaluate the effectiveness of each component of the adaptive treatment model in improving negative outcomes in the family caregivers.

This study will be conducted in two phases. Phase 1 will be used to develop an adaptive treatment model and risk report from which tailored treatment will be prescribed to participants in Phase 2. Participants in Phase 1 will attend four 90-minute interviews over 4 months. The first three interviews will be held in the first 3 to 4 weeks of the study and the last will be about 3 months later. In the first interview, participants will be asked about their experiences caring for their relatives, physical and emotional well-being, and ideas on helpful types of assistance. In the second and third interviews, participants will discuss their caregiving situations in more detail and will receive information about programs and services that may help them carry out caregiving activities. During the final interview, participants will again be asked about their experiences caring for their relatives.

Phase 2 of the study will test the adaptive treatment model developed in Phase 1. Participants in Phase 2 will attend an initial and final interview and up to 10 planning sessions. Each interview or planning session will last 60 to 75 minutes and will be tailored to the risks of each individual caregiver. During planning sessions, participants will discuss their caregiving situations in more detail, learn strategies to deal with stress, and receive information about programs and services that may help in carrying out caregiving activities. The strategies that participants will learn may include the following: new skills for communicating with the person receiving care, reflecting upon ways to reduce the impact of the changes that caregiving has had on their lives, learning more effective ways of communicating their own needs to other family members and friends, and identifying which types of services might be useful in caring for the person with dementia. The Phase 2 interviews will be the same as the initial and final interviews of Phase 1.

Study Phase
Study Type  Interventional
Study Design  Treatment, Non-Randomized, Open Label, Parallel Assignment, Efficacy Study
Primary Outcome Measure  Role overload [ Time Frame: Measured immediately after treatment ] [ Designated as safety issue: No ]
Secondary Outcome Measure  Nine-Item Depression Scale of the Patient Health Questionnaire (PHQ-9) [ Time Frame: Measured immediately after treatment ] [ Designated as safety issue: Yes ]
Condition  Stress
Intervention  Behavioral: Interviews with a single treatment planning session
Behavioral: Adaptive treatment model
MEDLINE PMIDs
Links
Recruitment Information Fields
Recruitment Status  Recruiting
Enrollment  60
Start Date  July 2006
Completion Date December 2008
Eligibility Criteria 

Inclusion Criteria:

  • Primary caregiver of a person suffering from any type of dementia and living in the community
Gender Both
Ages 18 Years and older
Accepts Healthy Volunteers Yes
Contacts ††
Contact: Carol J. Whitlatch, PhD     216-373-1629     cwhitlat@benrose.org    
Contact: Silvia Orsulic-Jeras, MSW     216-373-1629     sjeras@benrose.org    
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00632684
Organization ID R34 MH073559
Secondary IDs †† DATR A4-GPS
Study Sponsor  National Institute of Mental Health (NIMH)
Collaborators ††
Investigators 
Principal Investigator:     Steven H. Zarit, PhD     Penn State University    
Principal Investigator:     Carol J. Whitlatch, PhD     Benjamin Rose Institute    
Information Provided By National Institute of Mental Health (NIMH)
Verification Date March 2008
First Received Date  March 7, 2008
Last Updated Date March 20, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers